A suspected human cutaneous anthrax epidemic caused by butchering sick cattle occurred in Zhijin County of Guizhou Province, Southwest of China, in 2016. Epidemiological investigation and etiological analysis were performed to provide a scientific basis for the source tracking of the epidemic. The epidemic was epidemiologically investigated, and skin blister samples collected from patients and soil samples collected from the butchering spots were used for isolation. The suspicious isolates were identified using conventional methods and PCR, followed by genotyping using multiple-locus variable-number tandem repeats (VNTRs) analysis (MLVA-15) and canonical single-nucleotide polymorphism (canSNP). The genetic relationship of epidemic strains and isolates collected from other regions was analyzed. Epidemiological investigation results showed that the patients may be infected by during butchering sick cattle. Two suspected strains were isolated from blood samples and blister fluids, respectively. Conventional methods identified the two suspected isolates as , while PCR results showed that anti-protective antigen (PA) and capsule (CAP) gene were positive in the two isolates. MLVA-15 showed that the MLVA profiles of the two isolates were 9-20-12-53-16-2-8-8-8-4-4-4-4-10-4, which is different from the MLVA profiles of representative strains from other regions. CanSNP analysis showed that the two strains belonged to cluster A.Br.001/002. Clustering analysis and minimum spanning tree (MST) demonstrated that the two isolates were clustered with strains previously isolated from Guizhou Province. The results indicated that was the pathogen for this epidemic, and the patients were infected during butchering the sick. The genetic characteristics and the relationship of the isolates to strains from other regions indicated that the epidemic was a local occurrence.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109284 | PMC |
| http://dx.doi.org/10.3389/fpubh.2020.00065 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Review of clinical trials and guidelines for children and youth with mucopolysaccharidosis: outcome selection and measurement.
Orphanet J Rare Dis
October 2024
School of Epidemiology and Public Health, University of Ottawa, 600 Peter Morand Crescent, Ottawa, ON, K1G 5Z3, Canada.
Background: To inform the development of a core outcome set (COS) for children and youth with mucopolysaccharidoses (MPS), we aimed to identify all outcomes and associated outcome measurement instruments that are reported in recent clinical trials and recommended as measurements in clinical management guidelines.
Methods: To identify English-language clinical trials and guidelines pertaining to MPS published between 2011 and mid-2021, we applied a comprehensive peer-reviewed search strategy to relevant databases and registers on May 16, 2021. Two reviewers independently screened retrieved citations and then full-text articles to determine eligibility for inclusion.
Adaptive designs in clinical trials: a systematic review-part I.
BMC Med Res Methodol
October 2024
Department of Pharmacology and Therapeutics, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada.
Article Synopsis
- Adaptive designs (ADs) in clinical trials make the testing process more flexible and can save time and money.
- Many people in the medical field don’t fully understand how these designs work, so a review has been done to explain their use in research.
- The study looked at a lot of research reports from 2010 to 2020 and found that most ADs were used in trials for adults, especially for cancer treatments, with a smaller number for children.
Mother's milk microbiota is associated with the developing gut microbial consortia in very-low-birth-weight infants.
Cell Rep Med
September 2024
Department of Nutritional Sciences, University of Toronto, Toronto, ON, Canada; Translational Medicine Program, SickKids Research Institute, The Hospital for Sick Children, Toronto, ON, Canada; Joannah and Brian Lawson Centre for Child Nutrition, University of Toronto, Toronto, ON, Canada; Department of Pediatrics, Sinai Health, Toronto, ON, Canada; Rogers Hixon Ontario Human Milk Bank, Toronto, ON, Canada. Electronic address:
Article Synopsis
- - Mother's milk has diverse bacterial communities, and this study investigates how these bacteria affect the gut microbiota of very-low-birth-weight (VLBW) infants during hospitalization, analyzing 94 mother-infant pairs and 422 milk-stool samples.
- - Approximately 30%-40% of the bacterial types found in the infants' guts are also present in the mother's milk, showing a direct link between milk consumption and gut microbiota development in VLBW infants, influenced by feeding practices and antibiotic use.
- - The findings suggest that the microbiota in mother's milk plays a significant role in shaping the gut bacteria of VLBW infants, indicating that specific milk bacteria and their interactions are important for gut colonization.
Systematic Review: Measurement Properties of Patient-Reported Outcome Measures Used to Measure Depression Symptom Severity in Adolescents With Depression.
J Am Acad Child Adolesc Psychiatry
August 2024
Hospital for Sick Children, Toronto, Ontario, Canada; Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Article Synopsis
- - The study aimed to evaluate the effectiveness of 12 patient-reported outcome measures (PROMs) for assessing depression severity in adolescents, given the importance of accurately measuring depression in clinical settings.
- - Researchers conducted a comprehensive review using multiple databases and followed specific guidelines to assess various measurement properties of the PROMs, ultimately narrowing down to 31 studies for appraisal.
- - The review concluded that while some PROMs show promise in measuring depression in adolescents, none can currently be recommended for consistent use due to a lack of robust evidence and methodological issues, advising caution for clinicians and researchers.
Reporting of surrogate endpoints in randomised controlled trial reports (CONSORT-Surrogate): extension checklist with explanation and elaboration.
BMJ
July 2024
Centre for Research on Health and Social Care Management, Bocconi University, Milan 20136, Italy
Article Synopsis
- Randomised controlled trials often use surrogate endpoints instead of direct outcomes to enhance efficiency and reduce costs, but this can lead to increased uncertainty regarding treatment effects and intervention harms.
- A new guideline, known as CONSORT-Surrogate, provides a checklist for reporting trials that utilize surrogate endpoints, ensuring better clarity and transparency in the results.
- The recommended checklist, tailored for all stakeholders involved in clinical trials, aims to improve the reporting quality of these studies and ultimately reduce wasted research efforts.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!